CompuGroup Medical SE & Co. KGaA (FRA:COP)
Market Cap | 1.14B |
Revenue (ttm) | 1.19B |
Net Income (ttm) | 27.00M |
Shares Out | n/a |
EPS (ttm) | 0.52 |
PE Ratio | 42.23 |
Forward PE | 13.09 |
Dividend | 0.05 (0.23%) |
Ex-Dividend Date | Aug 4, 2025 |
Volume | 145,163 |
Average Volume | 58,434 |
Open | 22.06 |
Previous Close | 22.08 |
Day's Range | 22.00 - 22.18 |
52-Week Range | 13.10 - 28.92 |
Beta | n/a |
RSI | 42.23 |
Earnings Date | Apr 30, 2025 |
About FRA:COP
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions that cover all essential clinical, administrative, and billing functions, as well... [Read more]
Financial Performance
In 2024, FRA:COP's revenue was 1.19 billion, a decrease of -3.39% compared to the previous year's 1.23 billion. Earnings were 34.60 million, a decrease of -24.65%.
Financial StatementsNews

EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC 08.05.2025 / 22:09 CET/CEST The issuer is solely...

EQS-WpÜG: Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH
EQS-WpÜG: Caesar BidCo GmbH / Tender Offer Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH 08.05.2025 / 22:05 CET/CEST Dissemination of an announcement accor...

EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...

Q1/2025: CompuGroup Medical Faces a Slow Start
CompuGroup Medical started 2025 with a slight revenue increase, a strategic financial boost, and a strong focus on innovation, setting the stage for a promising year ahead. Jetzt den vollständigen Art...

EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results Q1/2025: CompuGroup Medical reports slow start into the year 30.04.2025 / 07:39 CET/CEST The iss...

EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes ef...

EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...